Report cover image

Global Sorafenib Tablet Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 99 Pages
SKU # APRC20340226

Description

Summary

According to APO Research, The global Sorafenib Tablet market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Sorafenib Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Sorafenib Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Sorafenib Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Sorafenib Tablet include Teva, Mylan, Bayer, Natco Pharma, MBA Pharmaceuticals Pvt Ltd, healthiza, Cipla, Aprazer and Aetos Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sorafenib Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sorafenib Tablet.

The Sorafenib Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sorafenib Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Sorafenib Tablet Segment by Company

Teva
Mylan
Bayer
Natco Pharma
MBA Pharmaceuticals Pvt Ltd
healthiza
Cipla
Aprazer
Aetos Pharma
Sorafenib Tablet Segment by Type

Patented Drugs
Generic Drugs
Sorafenib Tablet Segment by Application

Kidney Cancer
Other
Thyroid Cancer
Liver Cancer
Sorafenib Tablet Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sorafenib Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sorafenib Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sorafenib Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sorafenib Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Sorafenib Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

99 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Sorafenib Tablet Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Sorafenib Tablet Sales Estimates and Forecasts (2020-2031)
1.3 Sorafenib Tablet Market by Type
1.3.1 Patented Drugs
1.3.2 Generic Drugs
1.4 Global Sorafenib Tablet Market Size by Type
1.4.1 Global Sorafenib Tablet Market Size Overview by Type (2020-2031)
1.4.2 Global Sorafenib Tablet Historic Market Size Review by Type (2020-2025)
1.4.3 Global Sorafenib Tablet Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Sorafenib Tablet Sales Breakdown by Type (2020-2025)
1.5.2 Europe Sorafenib Tablet Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Sorafenib Tablet Sales Breakdown by Type (2020-2025)
1.5.4 South America Sorafenib Tablet Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Sorafenib Tablet Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Sorafenib Tablet Industry Trends
2.2 Sorafenib Tablet Industry Drivers
2.3 Sorafenib Tablet Industry Opportunities and Challenges
2.4 Sorafenib Tablet Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Sorafenib Tablet Revenue (2020-2025)
3.2 Global Top Players by Sorafenib Tablet Sales (2020-2025)
3.3 Global Top Players by Sorafenib Tablet Price (2020-2025)
3.4 Global Sorafenib Tablet Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Sorafenib Tablet Major Company Production Sites & Headquarters
3.6 Global Sorafenib Tablet Company, Product Type & Application
3.7 Global Sorafenib Tablet Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Sorafenib Tablet Market CR5 and HHI
3.8.2 Global Top 5 and 10 Sorafenib Tablet Players Market Share by Revenue in 2024
3.8.3 2023 Sorafenib Tablet Tier 1, Tier 2, and Tier 3
4 Sorafenib Tablet Regional Status and Outlook
4.1 Global Sorafenib Tablet Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Sorafenib Tablet Historic Market Size by Region
4.2.1 Global Sorafenib Tablet Sales in Volume by Region (2020-2025)
4.2.2 Global Sorafenib Tablet Sales in Value by Region (2020-2025)
4.2.3 Global Sorafenib Tablet Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Sorafenib Tablet Forecasted Market Size by Region
4.3.1 Global Sorafenib Tablet Sales in Volume by Region (2026-2031)
4.3.2 Global Sorafenib Tablet Sales in Value by Region (2026-2031)
4.3.3 Global Sorafenib Tablet Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Sorafenib Tablet by Application
5.1 Sorafenib Tablet Market by Application
5.1.1 Kidney Cancer
5.1.2 Other
5.1.3 Thyroid Cancer
5.1.4 Liver Cancer
5.2 Global Sorafenib Tablet Market Size by Application
5.2.1 Global Sorafenib Tablet Market Size Overview by Application (2020-2031)
5.2.2 Global Sorafenib Tablet Historic Market Size Review by Application (2020-2025)
5.2.3 Global Sorafenib Tablet Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Sorafenib Tablet Sales Breakdown by Application (2020-2025)
5.3.2 Europe Sorafenib Tablet Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Sorafenib Tablet Sales Breakdown by Application (2020-2025)
5.3.4 South America Sorafenib Tablet Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Sorafenib Tablet Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Teva
6.1.1 Teva Comapny Information
6.1.2 Teva Business Overview
6.1.3 Teva Sorafenib Tablet Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Teva Sorafenib Tablet Product Portfolio
6.1.5 Teva Recent Developments
6.2 Mylan
6.2.1 Mylan Comapny Information
6.2.2 Mylan Business Overview
6.2.3 Mylan Sorafenib Tablet Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan Sorafenib Tablet Product Portfolio
6.2.5 Mylan Recent Developments
6.3 Bayer
6.3.1 Bayer Comapny Information
6.3.2 Bayer Business Overview
6.3.3 Bayer Sorafenib Tablet Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer Sorafenib Tablet Product Portfolio
6.3.5 Bayer Recent Developments
6.4 Natco Pharma
6.4.1 Natco Pharma Comapny Information
6.4.2 Natco Pharma Business Overview
6.4.3 Natco Pharma Sorafenib Tablet Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Natco Pharma Sorafenib Tablet Product Portfolio
6.4.5 Natco Pharma Recent Developments
6.5 MBA Pharmaceuticals Pvt Ltd
6.5.1 MBA Pharmaceuticals Pvt Ltd Comapny Information
6.5.2 MBA Pharmaceuticals Pvt Ltd Business Overview
6.5.3 MBA Pharmaceuticals Pvt Ltd Sorafenib Tablet Sales, Revenue and Gross Margin (2020-2025)
6.5.4 MBA Pharmaceuticals Pvt Ltd Sorafenib Tablet Product Portfolio
6.5.5 MBA Pharmaceuticals Pvt Ltd Recent Developments
6.6 healthiza
6.6.1 healthiza Comapny Information
6.6.2 healthiza Business Overview
6.6.3 healthiza Sorafenib Tablet Sales, Revenue and Gross Margin (2020-2025)
6.6.4 healthiza Sorafenib Tablet Product Portfolio
6.6.5 healthiza Recent Developments
6.7 Cipla
6.7.1 Cipla Comapny Information
6.7.2 Cipla Business Overview
6.7.3 Cipla Sorafenib Tablet Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Sorafenib Tablet Product Portfolio
6.7.5 Cipla Recent Developments
6.8 Aprazer
6.8.1 Aprazer Comapny Information
6.8.2 Aprazer Business Overview
6.8.3 Aprazer Sorafenib Tablet Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Aprazer Sorafenib Tablet Product Portfolio
6.8.5 Aprazer Recent Developments
6.9 Aetos Pharma
6.9.1 Aetos Pharma Comapny Information
6.9.2 Aetos Pharma Business Overview
6.9.3 Aetos Pharma Sorafenib Tablet Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Aetos Pharma Sorafenib Tablet Product Portfolio
6.9.5 Aetos Pharma Recent Developments
7 North America by Country
7.1 North America Sorafenib Tablet Sales by Country
7.1.1 North America Sorafenib Tablet Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Sorafenib Tablet Sales by Country (2020-2025)
7.1.3 North America Sorafenib Tablet Sales Forecast by Country (2026-2031)
7.2 North America Sorafenib Tablet Market Size by Country
7.2.1 North America Sorafenib Tablet Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Sorafenib Tablet Market Size by Country (2020-2025)
7.2.3 North America Sorafenib Tablet Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Sorafenib Tablet Sales by Country
8.1.1 Europe Sorafenib Tablet Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Sorafenib Tablet Sales by Country (2020-2025)
8.1.3 Europe Sorafenib Tablet Sales Forecast by Country (2026-2031)
8.2 Europe Sorafenib Tablet Market Size by Country
8.2.1 Europe Sorafenib Tablet Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Sorafenib Tablet Market Size by Country (2020-2025)
8.2.3 Europe Sorafenib Tablet Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Sorafenib Tablet Sales by Country
9.1.1 Asia-Pacific Sorafenib Tablet Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Sorafenib Tablet Sales by Country (2020-2025)
9.1.3 Asia-Pacific Sorafenib Tablet Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Sorafenib Tablet Market Size by Country
9.2.1 Asia-Pacific Sorafenib Tablet Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Sorafenib Tablet Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Sorafenib Tablet Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Sorafenib Tablet Sales by Country
10.1.1 South America Sorafenib Tablet Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Sorafenib Tablet Sales by Country (2020-2025)
10.1.3 South America Sorafenib Tablet Sales Forecast by Country (2026-2031)
10.2 South America Sorafenib Tablet Market Size by Country
10.2.1 South America Sorafenib Tablet Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Sorafenib Tablet Market Size by Country (2020-2025)
10.2.3 South America Sorafenib Tablet Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Sorafenib Tablet Sales by Country
11.1.1 Middle East and Africa Sorafenib Tablet Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Sorafenib Tablet Sales by Country (2020-2025)
11.1.3 Middle East and Africa Sorafenib Tablet Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Sorafenib Tablet Market Size by Country
11.2.1 Middle East and Africa Sorafenib Tablet Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Sorafenib Tablet Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Sorafenib Tablet Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Sorafenib Tablet Value Chain Analysis
12.1.1 Sorafenib Tablet Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Sorafenib Tablet Production Mode & Process
12.2 Sorafenib Tablet Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Sorafenib Tablet Distributors
12.2.3 Sorafenib Tablet Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.